Why we backed Ozempic maker Novo Nordisk: SAINTS' James Dow

James Dow, the manager of Scottish American Investment Company, known as SAINTS, speaks to Simon Lambert about why even when investing for income, growth matters to investors - and the stocks he picks to deliver both.